BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: da Costa E Silva Carvalho S, Cury NM, Brotto DB, de Araujo LF, Rosa RCA, Texeira LA, Plaça JR, Marques AA, Peronni KC, Ruy PC, Molfetta GA, Moriguti JC, Carraro DM, Palmero EI, Ashton-Prolla P, de Faria Ferraz VE, Silva WA Jr. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. BMC Med Genomics 2020;13:21. [PMID: 32039725 DOI: 10.1186/s12920-019-0652-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Russi M, Marson D, Fermeglia A, Aulic S, Fermeglia M, Laurini E, Pricl S. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacol Ther 2021;:108009. [PMID: 34619284 DOI: 10.1016/j.pharmthera.2021.108009] [Reference Citation Analysis]
2 Bhattarai S, Sugita BM, Bortoletto SM, Fonseca AS, Cavalli LR, Aneja R. QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation. Int J Mol Sci 2021;22:11548. [PMID: 34768979 DOI: 10.3390/ijms222111548] [Reference Citation Analysis]
3 Dobbin EAF, Medeiros JAG, Costa MSCR, Rodrigues JCG, Guerreiro JF, Kroll JE, Souza SJ, de Assumpção PP, Ribeiro-Dos-Santos Â, Santos SEBD, Burbano RMR, Fernandes MR, Santos NPCD. Identification of Variants (rs11571707, rs144848, and rs11571769) in the BRCA2 Gene Associated with Hereditary Breast Cancer in Indigenous Populations of the Brazilian Amazon. Genes (Basel) 2021;12:142. [PMID: 33499154 DOI: 10.3390/genes12020142] [Reference Citation Analysis]
4 Baughan S, Tainsky MA. K3326X and Other C-Terminal BRCA2 Variants Implicated in Hereditary Cancer Syndromes: A Review. Cancers (Basel) 2021;13:447. [PMID: 33503928 DOI: 10.3390/cancers13030447] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Watters AK, Seltzer ES, MacKenzie D Jr, Young M, Muratori J, Hussein R, Sodoma AM, To J, Singh M, Zhang D. The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers. Genes (Basel) 2020;11:E829. [PMID: 32708251 DOI: 10.3390/genes11070829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
6 Suszynska M, Kozlowski P. Summary of BARD1 Mutations and Precise Estimation of Breast and Ovarian Cancer Risks Associated with the Mutations. Genes (Basel) 2020;11:E798. [PMID: 32679805 DOI: 10.3390/genes11070798] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Alenezi WM, Fierheller CT, Recio N, Tonin PN. Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers. Genes (Basel) 2020;11:E856. [PMID: 32726901 DOI: 10.3390/genes11080856] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sandoval RL, Leite ACR, Barbalho DM, Assad DX, Barroso R, Polidorio N, Dos Anjos CH, de Miranda AD, Ferreira ACSM, Fernandes GDS, Achatz MI. Germline molecular data in hereditary breast cancer in Brazil: Lessons from a large single-center analysis. PLoS One 2021;16:e0247363. [PMID: 33606809 DOI: 10.1371/journal.pone.0247363] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hinshaw JC, Zhao LP, Brimm JE, Payne TH, Hisama FM. Value of a genetics clinic evaluation in identifying women at risk for hereditary breast-ovarian cancer syndrome. J Genet Couns 2021. [PMID: 33881185 DOI: 10.1002/jgc4.1425] [Reference Citation Analysis]